Boehringer Ingelheim Capacity Update April 2025: Large Molecule Development

Discover the world of Boehringer Ingelheim BioXcellence™ in the session of OPCU, originally presented on April 22nd, 2025. This session provides a detailed overview of their contract manufacturing services for mammalian cell culture and microbial technologies. Gain insights into the global production network and the unique capabilities of the individual sites. Learn about the wide array of services offered, such as clinical and commercial supply, aseptic filling, and in-house analytic capabilities.

The presentation is a valuable opportunity for attendees to understand the operations and services of Boehringer Ingelheim BioXcellence™ in depth. With an experience of bringing 48 biopharmaceuticals to the market in collaboration with partners, they are ready for taking your biologic to commercial success. Learn more about our available capacity and how we can support you in brining your biologic to life!